VALIDATION OF CNS-IPI AND CORRELATION WITH CELL OF ORIGIN PROFILE IN A RETROSPECTIVE SERIES OF DLBCL PATIENTS TREATED WITH R-CHOP IN A SINGLE INSTITUTION

被引：0
|
作者：
Castellino, A.
Novo, M.
Chiappella, A.
Ciochetto, C.
Vittone, F.
Botto, B.
Cavallo, F.
Orsucci, L.
Boccomini, C.
Evangelista, A.
Ghione, P.
Nicolosi, M.
Santambrogio, E.
Ciccone, G.
Novero, D.
Vitolo, U.
机构：
[1] Univ Torino, Ematol, Turin, Italy
[2] AOU Citta Salute & Sci, Anat Patol, Turin, Italy
[3] AOU Citta Salute & Sci, CPO, Epidemiol Clin, Turin, Italy
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P150
引用
收藏
页码：111 / 111
页数：1
相关论文
共 50 条
  • [41] Prognostic value of serum soluble IL2 receptor (sIL2R) level in patients with diffuse large B cell lymphoma (DLBCL), treated with CHOP or R-CHOP based therapy
    Oki, Yasuhiro
    Matsuo, Keitaro
    Kato, Harumi
    Yamamoto, Kazuhito
    Kagami, Yoshitoyo
    Morishima, Yasuo
    BLOOD, 2007, 110 (11) : 469A - 469A
  • [42] Prognostic Significance of Survivin Expression in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP Therapy: A Report from the International DLBCL Rituximab-CHOP Consortium Program
    Liu, Zhiyu
    Xu-Monette, Zijun Y.
    Cao, Xin
    Visco, Carlo
    Tzankov, Alexander
    Montes-Moreno, Santiago
    Dybkaer, Karen
    Chiu, April
    Orazi, Attilio
    Zu, Youli
    Bhagat, Govind
    Richards, Kristy L.
    Hsi, Eric D.
    Choi, William W. L.
    van Krieken, J. Han
    Huh, Jooryung
    Ai, Weiyun
    Ponzoni, Maurilio
    Ferreri, Andres J. M.
    Farnen, John P.
    Moller, Michael B.
    Winter, Jane N.
    Piris, Miguel A.
    Medeiros, L. Jeffrey
    Young, Ken H.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S216 - S216
  • [43] Low Relapse Rate after 2 Years in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP and Achieved Complete Response
    Kang, Junho
    Lee, Kyoungmin
    Hong, Jung Yong
    Yoon, Dok Hyun
    Kim, Shin
    Park, Jung Sun
    Lee, Sang Wook
    Park, Chan-Sik
    Ryu, Jin-Sook
    Huh, Jooryung
    Suh, Cheolwon
    BLOOD, 2018, 132
  • [44] The international staging system improves the IPI risk stratification in patients with diffuse large B-cell lymphoma treated with R-CHOP (vol 7, 13592, 2017)
    Wei, Xiaolei
    Hao, Xiaoxiao
    Zhou, Lizhi
    Wei, Qi
    Zhang, Yuankun
    Huang, Weimin
    Song, Jialin
    Feng, Ru
    Wei, Yongqiang
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [45] Outcomes of Patients with Diffuse Large B Cell and High-Grade B Cell Lymphomas with Synchronous CNS and Systemic Involvement at Diagnosis Treated with High-Dose Methotrexate and R-CHOP: A Single-Center Retrospective Study
    Fleming, Megan
    Huang, Ying
    Dotson, Emily
    Bond, David A.
    Reneau, John C.
    Epperla, Narendranath
    Brammer, Jonathan E.
    Christian, Beth
    Alinari, Lapo
    Baiocchi, Robert
    Maddocks, Kami J.
    Sawalha, Yazeed
    BLOOD, 2021, 138
  • [46] The H/R FcγRIIA-131 polymorphism and survival in patients with diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP: a study in a genetically mixed population
    Levy, Debora
    Bellesso, Marcelo
    Oliveira-Souza, Pamela
    Maciel, Felipe V.
    Pereira, Juliana
    Bydlowski, Sergio P.
    CLINICS, 2011, 66 (05) : 919 - 922
  • [47] A single institution analysis of R-CHOP-14 vs.-21 in diffuse large B-cell lymphoma (DLBCL) in elderly patients
    Ruethrich, M. M.
    Hammersen, F. J.
    Hochhaus, A.
    La Rosee, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 36 - 36
  • [48] SERUM BETA2-MICROGLOBULIN IS AN INDEPENDENT STRONG PREDICTOR OF OS IN A POPULATION OF DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) PATIENTS TREATED WITH R-CHOP
    Conconi, A.
    Franceschetti, S.
    Casaluci, G. Margiotta
    Stathis, A.
    Bertoni, F.
    Ghielmini, M.
    Cavalli, F.
    Gaidano, G.
    Zucca, E.
    HAEMATOLOGICA, 2012, 97 : 126 - 127
  • [49] Prognostic Importance of Comorbidity in a Population-Based Analysis of Patients with Advanced-Stage Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP
    Wieringa, Andre
    van Roon, Eric N.
    Joosten, Peter
    Beerden, Tim
    Storm, Huib
    Kibbelaar, Robby
    Kluin-Nelemans, Hanneke C.
    Veeger, Nic J. G. M.
    Hoogendoorn, Mels
    BLOOD, 2012, 120 (21)
  • [50] The Hans classificator does not predict outcome in diffuse large B cell lymphoma in a large multicenter retrospective analysis of R-CHOP treated patients
    Ott, M. Michaela
    Horn, Heike
    Kaufmann, Martin
    Ott, German
    LEUKEMIA RESEARCH, 2012, 36 (05) : 544 - 545
12345